SU432712A3 - - Google Patents

Info

Publication number
SU432712A3
SU432712A3 SU1701181A SU1701181A SU432712A3 SU 432712 A3 SU432712 A3 SU 432712A3 SU 1701181 A SU1701181 A SU 1701181A SU 1701181 A SU1701181 A SU 1701181A SU 432712 A3 SU432712 A3 SU 432712A3
Authority
SU
USSR - Soviet Union
Prior art keywords
radical
lower alkyl
substituted
solution
general formula
Prior art date
Application number
SU1701181A
Other languages
English (en)
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of SU432712A3 publication Critical patent/SU432712A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
SU1701181A 1969-08-05 1970-07-28 SU432712A3 (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
SU432712A3 true SU432712A3 (lt) 1974-06-15

Family

ID=5741970

Family Applications (4)

Application Number Title Priority Date Filing Date
SU1701190A SU450398A3 (ru) 1969-08-05 1970-07-28 Способ получени -арил-2аминоалкоксистиролов
SU1700804A SU439965A3 (ru) 1969-08-05 1970-07-28 Способ получения -арил-2-аминоалкоксистилолов
SU1701179A SU428597A3 (ru) 1969-08-05 1970-07-28 СПОСОБ ПОЛУЧЕНИЯ р-АРИЛ-2-АМИНОАЛКОКСИСТИРОЛОВ
SU1701181A SU432712A3 (lt) 1969-08-05 1970-07-28

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SU1701190A SU450398A3 (ru) 1969-08-05 1970-07-28 Способ получени -арил-2аминоалкоксистиролов
SU1700804A SU439965A3 (ru) 1969-08-05 1970-07-28 Способ получения -арил-2-аминоалкоксистилолов
SU1701179A SU428597A3 (ru) 1969-08-05 1970-07-28 СПОСОБ ПОЛУЧЕНИЯ р-АРИЛ-2-АМИНОАЛКОКСИСТИРОЛОВ

Country Status (25)

Country Link
JP (6) JPS4941433B1 (lt)
KR (1) KR780000113B1 (lt)
AT (5) AT303055B (lt)
BE (1) BE754405A (lt)
BG (6) BG17950A3 (lt)
CH (6) CH548983A (lt)
CS (6) CS170538B2 (lt)
DE (1) DE1939809B2 (lt)
DK (1) DK139717B (lt)
ES (6) ES382429A1 (lt)
FI (1) FI54912C (lt)
FR (1) FR2068463B1 (lt)
GB (1) GB1307436A (lt)
HU (1) HU163185B (lt)
IE (1) IE34634B1 (lt)
IL (1) IL35047A (lt)
NL (1) NL7011590A (lt)
NO (1) NO135243C (lt)
PH (1) PH9520A (lt)
PL (2) PL78370B1 (lt)
RO (5) RO58861A2 (lt)
SE (1) SE382211B (lt)
SU (4) SU450398A3 (lt)
YU (2) YU198170A (lt)
ZA (1) ZA705411B (lt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (lt) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2943405A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP3284449B1 (en) 2011-06-10 2019-10-02 The Procter & Gamble Company Disposable diapers
PH12013502578A1 (en) 2011-06-10 2014-02-10 Procter & Gamble Absorbent core for disposable absorbent articles
CN103607989B (zh) 2011-06-10 2017-05-24 宝洁公司 用于吸收制品的吸收结构
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
PL2813201T3 (pl) 2013-06-14 2018-04-30 The Procter And Gamble Company Wyrób chłonny i wkład chłonny tworzący kanały w stanie mokrym
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
ES2606320T3 (es) 2013-12-19 2017-03-23 The Procter & Gamble Company Núcleos absorbentes que tienen áreas formadoras de canal y juntas de envoltura en c
CH718510A1 (de) * 2021-04-06 2022-10-14 Moser Schaffhausen Ag Zifferblatt für eine Uhr.

Also Published As

Publication number Publication date
GB1307436A (en) 1973-02-21
ES382427A1 (es) 1972-11-16
KR780000113B1 (en) 1978-04-15
JPS5113147B1 (lt) 1976-04-26
HU163185B (lt) 1973-06-28
DE1939809C3 (lt) 1979-01-11
ZA705411B (en) 1971-05-27
JPS4941433B1 (lt) 1974-11-08
SU450398A3 (ru) 1974-11-15
IE34634B1 (en) 1975-07-09
CH548368A (de) 1974-04-30
AT303055B (de) 1972-11-10
FI54912C (fi) 1979-04-10
JPS5113149B1 (lt) 1976-04-26
CS170536B2 (lt) 1976-08-27
DE1939809A1 (de) 1971-02-18
ES382430A1 (es) 1972-12-01
BG17950A3 (bg) 1974-03-05
AT302345B (de) 1972-10-10
SU439966A3 (ru) 1974-08-15
PL93130B1 (lt) 1977-05-30
AT301565B (de) 1972-09-11
RO58861A2 (ro) 1975-06-30
YU198170A (en) 1979-07-10
BE754405A (fr) 1971-02-04
IL35047A0 (en) 1970-10-30
AT302346B (de) 1972-10-10
CS170535B2 (lt) 1976-08-27
SE382211B (sv) 1976-01-19
BG20095A3 (bg) 1975-10-30
NO135243C (lt) 1977-03-09
CH548983A (de) 1974-05-15
RO57548A (lt) 1975-02-15
NO135243B (lt) 1976-11-29
CH548982A (de) 1974-05-15
YU37478A (en) 1979-07-10
DK139717B (da) 1979-04-02
PL78370B1 (lt) 1975-06-30
CS170538B2 (lt) 1976-08-27
SU439965A3 (ru) 1974-08-15
ES382429A1 (es) 1972-11-16
AT302344B (de) 1972-10-10
IE34634L (en) 1971-02-05
RO57793A (lt) 1975-03-15
JPS5113150B1 (lt) 1976-04-26
FR2068463A1 (lt) 1971-08-27
CH548367A (de) 1974-04-30
FR2068463B1 (lt) 1974-08-30
CS170533B2 (lt) 1976-08-27
ES382426A1 (es) 1972-11-16
NL7011590A (lt) 1971-02-09
DE1939809B2 (de) 1978-04-13
BG17951A3 (bg) 1974-03-05
CS170537B2 (lt) 1976-08-27
BG18599A3 (bg) 1975-02-25
ES382425A1 (es) 1972-11-16
PH9520A (en) 1976-01-09
RO57794A (lt) 1975-06-15
BG17952A3 (bg) 1974-03-05
DK139717C (lt) 1979-09-17
ES382428A1 (es) 1972-11-16
CS170534B2 (lt) 1976-08-27
IL35047A (en) 1973-05-31
JPS5113146B1 (lt) 1976-04-26
BG18600A3 (bg) 1975-02-25
CH548981A (de) 1974-05-15
CH548366A (de) 1974-04-30
FI54912B (fi) 1978-12-29
SU428597A3 (ru) 1974-05-15
JPS5113148B1 (lt) 1976-04-26
RO58837A (lt) 1975-09-15

Similar Documents

Publication Publication Date Title
JP2019218396A (ja) 5−フルオロ−4−イミノ−3−(アルキル/置換アルキル)−1−(アリールスルホニル)−3,4−ジヒドロピリミジン−2(1h)−オンおよびそれらの調製方法
BG64649B1 (bg) Нови дихидропиримидини
SU450398A3 (ru) Способ получени -арил-2аминоалкоксистиролов
CN110028489B (zh) 一种减压法制备苯甲酰胺类化合物的方法
WO2016040554A1 (en) Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
RU2688665C2 (ru) Новый способ получения производных триазина, пиримидина и пиридина
HUP9903886A2 (hu) Aza-cikloalkán-származékok, eljárás előállításukra és gyógyászati alkalmazásuk
US10392353B2 (en) Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
CZ220296A3 (en) Process for preparing derivatives of arylacetic acid esters and intermediates employed in the process
Kobayashi et al. Synthesis of 5, 6-disubstituted thieno [2, 3-d] pyrimidines from 4-chloropyrimidines
JPH06503564A (ja) 殺菌性イソキノリン誘導体
SU475768A3 (ru) Способ получени (5-нитрофурил-2) -пиридинов
US5250540A (en) Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments
KR101744046B1 (ko) 실로도신 합성에 유용한 중간체의 제조방법
KR20160027537A (ko) 실로도신의 제조방법
CN106220554B (zh) 一种芳基吡啶及其衍生物的制备方法
KR101665194B1 (ko) 테트라하이드로퀴놀린 유도체의 제조방법
RU2339619C2 (ru) Способ получения никотинальдегидов
CN114890963B (zh) 苯亚甲基噻唑烷二酮类衍生物及其制备方法和应用
RU2286342C2 (ru) Способ получения тетразамещенных производных имидазола и их новые кристаллические структуры
RU2475480C1 (ru) Способ получения 2-оксо-4-циано-1,2-дигидропиридин-3-карбоксамидов
US3278599A (en) 2-(benzyloxyalkyl)-4-phenylimino-1, 3-cyclopentanedione derivatives
DE3815046A1 (de) 3-chlor-2-methylphenethylaminoderivate
US2519411A (en) alpha-phenyl-alpha-(4-quinolyl) acetonitriles and method for their preparation
CN107325110B (zh) 一种四元杂环苯并噻吩并喹啉化合物及其合成方法